Literature DB >> 19146845

Screening for congenital disorders of glycosylation (CDG): transferrin HPLC versus isoelectric focusing (IEF).

Ester Quintana1, Aleix Navarro-Sastre, José María Hernández-Pérez, Judit García-Villoria, Raquel Montero, Rafael Artuch, Antonia Ribes, Paz Briones.   

Abstract

OBJECTIVES: Transferrin isoelectrofocusing (Tf-IEF) is widely used to screen for Congenital Disorders of Glycosylation (CDG), but it is laborious, time-consuming, and not suitable for automation or accurate quantification. We present our experience and advantages of the implementation of Tf-HPLC.
METHODS: Sera were iron saturated, lipid precipitated and filtrated on Microcon-YM10. Glycoforms were separated by HPLC on a SOURCE 15Q anion-exchange column. Detection was at 470 nm.
RESULTS: We established reference values and validated the HPLC method by analysing samples with abnormal Tf-IEF. Comparison between both methods is described.
CONCLUSIONS: HPLC is useful for CDG screening, especially for laboratories that deal with great number of samples, due to its easy sample processing, the possibility of performing long series of analysis and the advantage of peak quantification, which allows objective interpretations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19146845     DOI: 10.1016/j.clinbiochem.2008.12.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  9 in total

1.  Two Argentinean Siblings with CDG-Ix: A Novel Type of Congenital Disorder of Glycosylation?

Authors:  M B Bistué Millón; M A Delgado; N B Azar; N Guelbert; L Sturiale; D Garozzo; G Matthijs; J Jaeken; Raquel Dodelson de Kremer; C G Asteggiano
Journal:  JIMD Rep       Date:  2011-06-22

2.  The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations.

Authors:  B Pérez; P Briones; D Quelhas; R Artuch; A I Vega; E Quintana; L Gort; M J Ecay; G Matthijs; M Ugarte; C Pérez-Cerdá
Journal:  JIMD Rep       Date:  2011-06-22

3.  N- and O-linked glycosylation of total plasma glycoproteins in galactosemia.

Authors:  Ying Liu; Baoyun Xia; Tyler J Gleason; Uriel Castañeda; Miao He; Gerard T Berry; Judith L Fridovich-Keil
Journal:  Mol Genet Metab       Date:  2012-06-12       Impact factor: 4.797

4.  Genetic predisposition to fetal alcohol syndrome: association with congenital disorders of N-glycosylation.

Authors:  María E de la Morena-Barrio; María J Ballesta-Martínez; Raquel López-Gálvez; Ana I Antón; Vanessa López-González; Laia Martínez-Ribot; José Padilla; Antonia Miñano; Oscar García-Algar; Miguel Del Campo; Javier Corral; Encarna Guillén-Navarro; Vicente Vicente
Journal:  Pediatr Res       Date:  2017-09-20       Impact factor: 3.756

5.  Comparison of transferrin isoform analysis by capillary electrophoresis and HPLC for screening congenital disorders of glycosylation.

Authors:  Mihika B Dave; Alpa J Dherai; Vrajesh P Udani; Anaita U Hegde; Neelu A Desai; Tester F Ashavaid
Journal:  J Clin Lab Anal       Date:  2017-02-25       Impact factor: 2.352

6.  Classical Galactosaemia and CDG, the N-Glycosylation Interface. A Review.

Authors:  Ashwini Maratha; Hugh-Owen Colhoun; Ina Knerr; Karen P Coss; Peter Doran; Eileen P Treacy
Journal:  JIMD Rep       Date:  2016-08-09

7.  IgG N-Glycosylation Galactose Incorporation Ratios for the Monitoring of Classical Galactosaemia.

Authors:  Henning Stockmann; Karen P Coss; M Estela Rubio-Gozalbo; Ina Knerr; Maria Fitzgibbon; Ashwini Maratha; James Wilson; Pauline Rudd; Eileen P Treacy
Journal:  JIMD Rep       Date:  2015-09-30

8.  Abnormal N-glycan fucosylation, galactosylation, and sialylation of IgG in adults with classical galactosemia, influence of dietary galactose intake.

Authors:  Eileen P Treacy; Sebastian Vencken; Annet M Bosch; Matthias Gautschi; Estela Rubio-Gozalbo; Charlotte Dawson; Darragh Nerney; Hugh Owen Colhoun; Loai Shakerdi; Gregory M Pastores; Roisin O'Flaherty; Radka Saldova
Journal:  JIMD Rep       Date:  2021-07-22

9.  GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients.

Authors:  Maria E de la Morena-Barrio; Trinidad Hernández-Caselles; Javier Corral; Roberto García-López; Irene Martínez-Martínez; Belen Pérez-Dueñas; Carmen Altisent; Teresa Sevivas; Soren R Kristensen; Encarna Guillén-Navarro; Antonia Miñano; Vicente Vicente; Jaak Jaeken; Maria L Lozano
Journal:  Orphanet J Rare Dis       Date:  2013-10-20       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.